ClassID:

94454

C07D235/28 - CPC Classification

Classification description:

Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems; Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2 Sulfur atoms

Recent Application in this class:
#1
20250368608
2025-12-04

SELECTIVE HDAC6 INHIBITOR

#2
20250102440
2025-03-27

SERS METHOD FOR ERGOTHIONEINE QUANTIFICATION BY SURFACE-AMPLIFIED RAMAN SCATTERING SPECTROSCOPY

#3
20240327707
2024-10-03

HETEROARYL-THIO-SUBSTITUTED PYRONES

#4
20240285772
2024-08-29

PNICTOGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND THEIR USE

#5
20240208944
2024-06-27

Quinazoline Derivatives, Pharmaceutical Compositions, and Therapeutic Uses Related to Nox Inhibition

#6
20240150287
2024-05-09

N-(BENZOYL)-PHENYLALANINE COMPOUND, PHARMACEUTICAL COMPOSITION CONTAINING SAME, AND USE THEREOF

#7
20240132479
2024-04-25

THERAPEUTIC COMPOUNDS AND USES THEREOF

#8
20230150927
2023-05-18

Cannabigerol derivatives and use thereof as cannabinoid receptor modulators

#9
20230124700
2023-04-20

OXAZOLE AND THIOAZOLE-TYPE CULLIN RING UBIQUITIN LIGASE COMPOUNDS AND USES THEREOF

#10
20220151991
2022-05-19

SMALL MOLECULE GRB2 STABILIZERS FOR RAS MAP KINASE INHIBITION

#11
20220119709
2022-04-21

Heteroaryl-thio-substituted pyrones

#12
20220073495
2022-03-10

METHODS AND COMPOSITIONS FOR THE TREATMENT OF INFLUENZA

#13
20210238159
2021-08-05

Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use

#14
20210147415
2021-05-20

INHIBITORS OF NHR2 AND/OR RUNX1/ETO-TETRAMERIZATION

#15
20210078885
2021-03-18

Method for monitoring fluorescent polymer antiscalants in industrial water systems

#16
20200325347
2020-10-15

Slippery liquid-infused porous surfaces that prevent microbial surface fouling

#17
20200277276
2020-09-03

Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use

#18
20200277275
2020-09-03

Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use

#19
20200277274
2020-09-03

Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use

#20
20200277273
2020-09-03

Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use

#21
20200277265
2020-09-03

Compounds, process for obtaining the compounds, pharmaceutical composition, use of the compounds and method for treating psychiatric disorders and/or sleep disorders

#22
20190270711
2019-09-05

Compounds, process for obtaining the compounds, pharmaceutical composition, use of the compounds and method for treating psychiatric disorders and/or sleep disorders

#23
20190269658
2019-09-05

Pharmaceutical compositions directly targeting FKBP52 for the treatment of prostate cancer and methods of using same

#24
20190144396
2019-05-16

9-MEMBERED FUSED RING DERIVATIVE

#25
20190112328
2019-04-18

Diarylsulfide backbone containing photolabile protecting groups

#26
20190105646
2019-04-11

Ion pair catalysis of tungstate and molybdate

#27
20190077784
2019-03-14

Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use

#28
20190016686
2019-01-17

SALTS OF COMPOUNDS HAVING A BENZIMIDAZOLIC STRUCTURE, USES AND PROCESS FOR THE PREPARATION THEREOF

#29
20180370911
2018-12-27

Photocatalyst-free, light-induced carbon-sulfur cross-coupling methods

#30
20180346392
2018-12-06

THIOETHER COMPOUNDS AS NITRIFICATION INHIBITORS

#31
20180297959
2018-10-18

Benzimidazole derivatives, preparation method therefor, and applications thereof

#32
20180230318
2018-08-16

Slippery liquid-infused porous surfaces that prevent microbial surface fouling

#33
20180230143
2018-08-16

INHIBITORS OF NHR2 AND/OR RUNX1/ETO-TETRAMERIZATION

#34
20180161313
2018-06-14

Inhibitors of Mc1-1 as drugs to overcome resistance to BRAF inhibitors and MEK inhibitors

#35
20180134633
2018-05-17

Thioether compounds as nitrification inhibitors

#36
20180079727
2018-03-22

9-membered fused ring derivative

#37
20180029979
2018-02-01

Isothiocyanate compounds and isothiocyanate XPO1 protein inhibitor drugs thereof

#38
20180002821
2018-01-04

LOW DOSAGE CHEMICAL SUPPRESSION AGENTS FOR CARBON STEELS DEGRADATION

#39
20180002820
2018-01-04

COMPOSITION AND METHOD FOR INHIBITING CORROSION OF METALS

#40
20170327470
2017-11-16

Hydrosoluble compounds derived from benzimidazole used in treating fasciolosis

#41
20170313891
2017-11-02

2-mercaptobenzimidazole derivatives as corrosion inhibitors

#42
20170231964
2017-08-17

Pharmaceutical compositions directly targeting FKBP52 for the treatment of prostate cancer and methods of using same

#43
20170145047
2017-05-25

Diarylsulfide backbone containing photolabile protecting groups

#44
20170029387
2017-02-02

MIF inhibitors

#45
20160333009
2016-11-17

Benzimidazole and imadazopyridine carboximidamide compounds

#46
20160251317
2016-09-01

Parasiticidal compositions comprising benzimidazole derivatives, methods and uses thereof

#47
20160130234
2016-05-12

PHARMACEUTICAL COMPOSITIONS BASED ON PHOTOCHEMICALLY STABLE SILVER COMPLEXES, CHLOREXIDINE AND CATIONIC SURFACTANTS

#48
20160115136
2016-04-28

COMPOUNDS, COMPOSITIONS COMPRSING SAME, AND METHODS RELATED THERETO

#49
20160052890
2016-02-25

Compounds useful as antibiotic tolerance inhibitors

#50
20150313898
2015-11-05

Compounds that inhibit human DNA ligases and methods of treating cancer

#51
20150266827
2015-09-24

Antibiotic Tolerance Inhibitors

#52
20150238475
2015-08-27

Inhibition of quorum sensing-mediated processes in bacteria

#53
20150166485
2015-06-18

Parasiticidal compositions comprising benzimidazole derivatives, methods and uses thereof

#54
20150025094
2015-01-22

Compounds and compositions for use in augmentation of glucose

#55
20150004533
2015-01-01

Actinic ray-sensitive or radiation-sensitive resin composition, and, actinic ray-sensitive or radiation-sensitive film and pattern forming method, each using the same

#56
20140275224
2014-09-18

CYTOSINE DEAMINASE MODULATORS FOR ENHANCEMENT OF DNA TRANSFECTION

#57
20140221658
2014-08-07

Inhibition of cell proliferation

#58
20140187672
2014-07-03

Corrosion-inhibiting microgels and non-chromated primer compositions incorporating the same

#59
20140113891
2014-04-24

Compounds that inhibit human DNA ligases and methods of treating cancer

#60
20140100242
2014-04-10

Inhibition of quorum sensing-mediated processes in bacteria

#61
20140080828
2014-03-20

Imidazolyl amide compounds and uses related thereto

#62
20140073639
2014-03-13

INHIBITION OF ANTIMICROBIAL TARGETS WITH REDUCED POTENTIAL FOR RESISTANCE

#63
20140066454
2014-03-06

Antibiotic tolerance inhibitors

#64
20140066419
2014-03-06

Hydroxamic acid derivatives

#65
20130345261
2013-12-26

Benzimidazole inhibition of biofilm formation

#66
20130303781
2013-11-14

PROCESS FOR PREPARATION OF TRICLABENDAZOLE

#67
20130281392
2013-10-24

Parasiticidal compositions comprising benzimidazole derivatives, methods and uses thereof

#68
20130065927
2013-03-14

Forms of dexlansoprazole and processes for the preparation thereof

#69
20130012714
2013-01-10

NOVEL SOLVATE OF DEXLANSOPRAZOLE

#70
20120276050
2012-11-01

Methods and compositions of treating a flaviviridae family viral infection

#71
20120258891
2012-10-11

DIARYLSULFIDE BACKBONE CONTAINING PHOTOLABILE PROTECTING GROUPS

#72
20120071489
2012-03-22

Derivatives of N-acyl-N′-phenylpiperazine useful (inter alia) for the prophylaxis or treatment of diabetes

#73
20120015911
2012-01-19

Method and compositions for treating amyloid-related diseases

#74
20110269706
2011-11-03

Hydroxamic acid derivatives

#75
20110245231
2011-10-06

ACTIVE SUBSTANCE AND PHARMACEUTICAL COMPOSITION FOR TREATING ALCOHOL DEPENDENCE, AND A METHOD FOR OBTAINING AND THE USE OF SAID ACTIVE SUBSTANCE

#76
20110224427
2011-09-15

Systems for carbon dioxide and sulfur dioxide removal

#77
20110195964
2011-08-11

Cyclic benzimidazole derivatives useful as anti-diabetic agents

#78
20110129762
2011-06-02

METHOD OF INCREASING HYDROPHILIC PROPERTY OF CRYSTALLINE CARBON USING SURFACE MODIFIER AND METHOD OF PREPARING PLATINUM CATALYST USING THE SAME

#79
20110123586
2011-05-26

Inhibition of quorum sensing-mediated processes in bacteria

#80
20110112151
2011-05-12

COMPOUND CAPABLE OF INHIBITING 11-BETA HYDROXYSTERIOD DEHYDROGENASE

#81
20110082143
2011-04-07

Bicyclic heteroaryl compounds

#82
20110021509
2011-01-27

PDE10 inhibitors and related compositions and methods

#83
20100323999
2010-12-23

Therapeutic Molecules and Methods-1

#84
20100311787
2010-12-09

Compounds for inflammation and immune-related uses

#85
20100210846
2010-08-19

Process for preparing 2-(2-pyridylmethyl)-sulfinyl-1H-benzimidazoles and the intermediate compounds used therein

#86
20100113591
2010-05-06

Methods and compositions for treating amyloid-related diseases

#87
20100113522
2010-05-06

Compounds for the modulation of PPARγ activity

#88
20100099683
2010-04-22

Compounds that inhibit human DNA ligases and methods of treating cancer

#89
20100081643
2010-04-01

Cyclic benzimidazole derivatives useful as anti-diabetic agents

#90
20100048893
2010-02-25

Substituted arylalkanoic acid derivatives and use thereof

#91
20100041891
2010-02-18

AMIDE COMPOUND

#92
20090318514
2009-12-24

Novel Pharmaceutical Compositions

#93
20090181943
2009-07-16

Inhibitors of histone deacetylase

#94
20090170922
2009-07-02

Benzimidazole derivatives and their use as a medicament

#95
20090076279
2009-03-19

Reaction products of mercaptobenzothiazoles, mercaptothiazolines, and mercaptobenzimidalzoles with epoxides as lubricant additives

#96
20090062530
2009-03-05

Substituted arylalkanoic acid derivatives and use thereof

#97
20080319195
2008-12-25

Enantioselective Preparation of Benzimidazole Derivatives and Their Salts

#98
20080300240
2008-12-04

PDE10 inhibitors and related compositions and methods

#99
20080293745
2008-11-27

New amino-alkyl-amide derivatives as CCR3 receptor ligands

#100
20080280963
2008-11-13

New amino-alkyl-amide derivatives as CCR3 receptor ligands

#101
20080108638
2008-05-08

2-sulfanyl-benzoimidazol-1-yi-acetic acid derivatives as CRTH2 antagonists

#102
20080096903
2008-04-24

SULFAMOYL-CONTAINING DERIVATIVES AND USES THEREOF

#103
20080090889
2008-04-17

Substituted 2-aminoalkylthiobenzimidazole compounds, pharmaceutical compositions thereof and methods for their use

#104
20080090855
2008-04-17

Substituted cyclic urea derivatives and the use thereof as vanilloid receptor 1 modulators

#105
20080021069
2008-01-24

Receptor Function Regulating Agent

#106
20080015190
2008-01-17

Inhibitors of Histone Deacetylase

#107
20070293682
2007-12-20

Methods of Preparing Sulfinamides and Sulfoxides

#108
20070293495
2007-12-20

BETA-AMYLOID PROTEIN PRODUCTION/SECRETION INHIBITORS

#109
20070275995
2007-11-29

Thiobenzimidazole derivatives

#110
20070259932
2007-11-08

Benzimidazole derivatives, their production and use

#111
20070254318
2007-11-01

Inhibition of cell proliferation

#112
20070249661
2007-10-25

Compounds for inflammation and immune-related uses

#113
20070213333
2007-09-13

Substituted arylalkanoic acid derivatives and use thereof

#114
20070173527
2007-07-26

HISTONE DEACETYLASE INHIBITORS

#115
20070010573
2007-01-11

Methods and compositions for treating amyloid-related diseases

#116
20060223855
2006-10-05

Methods and compositions for treating amyloid-related diseases

#117
20060178345
2006-08-10

Substituted alcohols useful in treatment of Alzheimer's disease

#118
20060166960
2006-07-27

Imidazole and benzimidazole derivatives useful as histamine Hantagonists

#119
20060165605
2006-07-27

Process to regenerate fcc spent catalyst

#120
20060154977
2006-07-13

Therapeutic molecules and methods-1

#121
20060128767
2006-06-15

Methods of preparing sulfinamides and sulfoxides

#122
20060111355
2006-05-25

Gonadotropin releasing hormone receptor antagonists

#123
20060040976
2006-02-23

Thiobenzimidazole derivatives

#124
20060035906
2006-02-16

Process for production of 1-[2-(benzimidazol-2-yl-thio)ethyl]piperazine or salts thereof

#125
20060030565
2006-02-09

Amide derivatives and nociceptin antagonists

#126
20050272036
2005-12-08

Ketones

#127
20050234109
2005-10-20

β-amyloid protein production/secretion inhibitor

#128
20050143439
2005-06-30

1-aryl-2-N-, S- or O-substituted benzimidazole derivatives, their use for the production of pharmaceutical agents as well as pharmaceutical preparations that contain these derivatives

#129
20050131039
2005-06-16

Benzimidazole derivatives, their production and use

#130
20050075334
2005-04-07

Novel compounds

#131
20050054639
2005-03-10

Non-nucleoside reverse transcriptase inhibitors

#132
20050049290
2005-03-03

Benzimidazole derivatives and their use as GnRH antagonists

#133
20050037931
2005-02-17

Reaction products of mercaptobenzothiazoles, mercaptothiazolines, and mercaptobenzimidazoles with epoxides as lubricant additives

#134
20050032814
2005-02-10

Process for production of cyclic diamine compounds or salts thereof

#135
20050026972
2005-02-03

Benzimidazol- or indol-aminoacetonitrile derivatives for parasite control

#136
20050014812
2005-01-20

Benzimidazole compounds